Clinical Trials Arena
Hard data and deep insights on clinical trials strategy & operations
- Website
- clinicaltrialsarena.com · all feeds from this site
- Feed URL
https://www.clinicaltrialsarena.com/feed/
Read it in your FeedListing reader
Or add to: Feedly Inoreader Raw feed
Latest posts
-
Pretzel gains UK approval for PX578 trial to treat mitochondrial disorder
Pretzel Therapeutics has received authorisation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to proceed with clinical trial of PX578 in patients with POLG-mediated primary mitochondrial disorders. The post Pretzel gains UK approval for PX578 trial to…
-
Zhimeng Biopharma concludes enrolment in ALS trial of CB03-154
Shanghai Zhimeng Biopharma has completed patient enrolment in the pivotal Phase II/III clinical trial of CB03-154 for ALS. The post Zhimeng Biopharma concludes enrolment in ALS trial of CB03-154 appeared first on Clinical Trials Arena .
-
How sponsors can accelerate contracting and budget negotiations
IQVIA executives, Rajesh Patel and Vikas Basal, say that sponsors can use AI and previous contracts to accelerate new agreements. The post How sponsors can accelerate contracting and budget negotiations appeared first on Clinical Trials Arena .
-
AstraZeneca cans late-stage Ultomiris trial on lacklustre efficacy predictions
Ultomiris, one of AstraZeneca’s blockbuster sellers in Q3, is currently approved across five rare disease indications. The post AstraZeneca cans late-stage Ultomiris trial on lacklustre efficacy predictions appeared first on Clinical Trials Arena .
-
Geron winds down Phase III rare blood cancer trial after muted efficacy
Geron will now focus on Rytelo’s combinatory potential alongside SoC JAK inhibitor, Jakafi in frontline myelofibrosis. The post Geron winds down Phase III rare blood cancer trial after muted efficacy appeared first on Clinical Trials Arena .
-
Starton and Stanford to study STAR-LLD combination in MM
Starton Therapeutics has entered a clinical trial agreement with the Stanford School of Medicine to assess its STAR-LLD candidate alongside a new CAR-T cell therapy for MM. The post Starton and Stanford to study STAR-LLD combination in MM appeared first on Clinical Trials Arena .
-
Nuvation Bio to broaden Phase III glioma trial into Europe
Nuvation Bio is set to expand its pivotal Phase III SIGMA trial into Europe to evaluate safusidenib in patients with IDH1-mutant glioma. The post Nuvation Bio to broaden Phase III glioma trial into Europe appeared first on Clinical Trials Arena .
-
Genmab’s bispecific halves risk of death in first-line HNSCC
Genmab is going to approach global agencies based on the interim Phase III data for its bispecific in first-line HNSCC. The post Genmab’s bispecific halves risk of death in first-line HNSCC appeared first on Clinical Trials Arena .
-
ESMO26: Iza-bren leads post-TKI ADCs on efficacy, but toxicity could decide
Arriving after rivals offering smaller PFS gains but fewer serious adverse events, iza-bren will need its early OS advantage to hold. The post ESMO26: Iza-bren leads post-TKI ADCs on efficacy, but toxicity could decide appeared first on Clinical Trials Arena .
-
Sobi’s gout drug shows durability in Phase III study
Following this positive data, Sobi will now look ahead to its second pivotal readout for pozdeutinurad in uncontrolled gout. The post Sobi’s gout drug shows durability in Phase III study appeared first on Clinical Trials Arena .
-
Podcast: ESMO26: Major readouts from the 2026 congress
This week's podcast features the Clinical Trials Arena team and GlobalData analysts who discuss the biggest study readouts from the ESMO Congress 2026. The post Podcast: ESMO26: Major readouts from the 2026 congress appeared first on Clinical Trials Arena .
-
Navigating the complexities of running clinical trials amid disruption
Experts at OCT & CTS Nordics 2026 noted that strategic planning is non-negotiable in the midst of events like conflict and extreme weather. The post Navigating the complexities of running clinical trials amid disruption appeared first on Clinical Trials Arena .
-
United Therapeutics secures FDA clearance for PAH Phase I trial
United Therapeutics has received clearance from the US FDA under an IND to initiate a Phase I trial assessing Treprostinil-Iloprost SMI as a potential treatment for PAH. The post United Therapeutics secures FDA clearance for PAH Phase I trial appeared first on Clinical Trials…
-
First patient dosed in Nacuity’s Phase III Usher syndrome RP trial
Nacuity Pharmaceuticals has dosed the first patient in its global confirmatory Phase III SLO-RP Preserve study evaluating NPI-001 for RP associated with Usher syndrome. The post First patient dosed in Nacuity’s Phase III Usher syndrome RP trial appeared first on Clinical Trials…